Preclinical research on Epithalon and circadian rhythm regulation, pineal gland function, melatonin secretion, and PERIOD gene expression in aged rodent models.
Explore BPC-157 neurological research: dopaminergic, serotonergic, and GABAergic pathways, neuroprotection, and depression-like behaviour in rodent models.
Preclinical overview of GHK-Cu TB-500 tissue repair: collagen synthesis, actin sequestration, ECM remodelling, and angiogenesis in rodent wound models.
Explore preclinical research on Selank and Pinealon neuropeptides: GABA-A modulation, epigenetic neuroprotection, and complementary rodent model findings.
Explore preclinical research on the CJC-1295 MOTS-c stack: GH axis amplification paired with mitochondrial AMPK activation across animal model studies.
Explore preclinical NAD+ Epithalon longevity research: sirtuin/PARP and telomere pathways, parallel aging hallmarks, and animal-model co-administration data.
Preclinical research on the BPC-157 GHK-Cu stack examines complementary angiogenic, collagen-synthesis, and anti-fibrotic mechanisms in tissue repair models.
TB-500 (Thymosin Beta-4) research documents actin sequestration, angiogenesis, and muscle, tendon, and cardiac repair in preclinical animal models. Full review.
Melanotan-2 research covers MC1R and MC4R agonism, skin pigmentation in animal models, and neuroprotective melanocortin signalling in preclinical studies.
Orforglipron GLP-1 research: non-peptide small molecule, oral bioavailability, ATTAIN phase 3 data, and mechanistic comparison to semaglutide and tirzepatide.